-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cisplatin is a widely used cancer chemotherapy drug that has been in use for over five decades.
It is an effective treatment for a variety of different types of cancer, including testicular, ovarian, and bladder cancer.
Cisplatin is a platinum-based drug, and it works by interfering with the normal functioning of DNA replication and repair mechanisms in cancer cells.
The synthesis of cisplatin has been extensively studied, and there are several different synthetic routes that have been developed over the years.
The earliest synthetic routes for cisplatin involved the use of laborious and expensive methods, but modern synthetic methods have been developed that are more efficient and cost-effective.
One of the earliest synthetic routes for cisplatin involved the reduction of chloroplatinic acid with sodium hydroxide to form the platinum complex, which was then treated with a base to form the cis-diamminedichloroplatinum (II) salt.
This salt was then converted into the cis-platinum (II) oxine complex through a series of chemical reactions.
A more efficient synthetic route for cisplatin involves the use of hydrogenation of platinum complexes.
This method involves the reduction of a platinum complex with hydrogen gas under high pressure in the presence of a noble metal catalyst.
The cis-platinum (II) oxine complex is then formed through a series of chemical reactions.
Another synthetic route for cisplatin involves the use of somatic cell fusion.
This method involves the fusion of animal cells with cancer cells to form hybridoma cells, which can then be cultured in the laboratory to produce large quantities of cisplatin.
In recent years, synthetic routes for cisplatin have become increasingly complex and sophisticated.
One example of this is the use of organometallic complexes, which involve the use of metal complexes with organic ligands.
These complexes have been shown to be highly effective in the synthesis of cisplatin and have the potential to be developed into more efficient and cost-effective synthetic routes in the future.
Overall, the synthetic routes for cisplatin have undergone significant changes over the years, with newer, more efficient methods being developed all the time.
These developments have made it possible to produce cisplatin in larger quantities and at a lower cost, making it more accessible to cancer patients who need it.
As research continues to advance, it is likely that new and more efficient synthetic routes for cisplatin will be developed, leading to further improvements in the production of this important cancer treatment drug.